8-K EDGAR Filing

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 8-K


 


 


CURRENT REPORT


 

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report:   April 13, 2004

(Date of earliest event reported)


 

KIMBERLY-CLARK CORPORATION

(Exact name of registrant as specified in its charter)



 

 

Delaware 1-225 39-0394230

(State or other jurisdiction of

incorporation)

(Commission File

Number)

(I.R.S. Employer

Identification No.)

P. O. Box 619100, Dallas, Texas   75261-9100
(Address of principal executive offices)   (Zip Code)

 

(972) 281-1200

 

(Registrant’s telephone number, including area code)




1


Item 9. Regulation FD Disclosure

Attached hereto as Exhibit 99 is a summary that reflects reclassifications in the composition of Kimberly-Clark Corporation’s Personal Care and Consumer Tissue business segments, as a result of organizational changes announced on January 19, 2004. As part of the reorganization, the baby wipes business was moved from Consumer Tissue to Personal Care. The summary includes: the effect of the reclassifications included in Net Sales and Operating Profit for the full years 2001 and 2002 and by quarter for 2003; and Depreciation Expense, Assets and Capital Spending for 2002 and 2003.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

KIMBERLY-CLARK CORPORATION

Date: April 13, 2004 By:     /s/    MARK A. BUTHMAN        

Mark A. Buthman
Senior Vice President and
Chief Financial Officer

 

 

2


EXHIBIT INDEX

(99)

 

Personal Care and Consumer Tissue business segments’ Net Sales and Operating Profit (as reclassified) for full-years 2001 and 2002, and by quarter for 2003 and Depreciation Expense, Assets and Capital Spending (as reclassified) for 2002 and 2003.

 

 

 

3


 

Exhibit (99)

KIMBERLY-CLARK CORPORATION


 

NET SALES AND OPERATING PROFIT BY BUSINESS SEGMENT

(as reclassified)


 
  NET SALES

($ millions)
Personal
Care
Consumer
Tissue
Intersegment
Sales
2001 Year      $   5,523 .2 $   4,381 .3 $    (161 .5)
2002 Year   5,485 .5 4,635 .2 (147 .4)
2003              
     1st Quarter   1,385 .3 1,222 .5 (35 .9)
     2nd Quarter   1,427 .1 1,189 .0 (38 .9)
     3rd Quarter   1,432 .1 1,278 .1 (39 .5)
     4th Quarter   1,408 .4 1,357 .1 (38 .1)
               
     Year   $   5,652 .9 $   5,046 .7 $    (152 .4)






OPERATING PROFIT

($ millions)
Personal
Care
Consumer
Tissue
2001 Year   $   1,164 .8 $      741 .6
2002 Year   1,157 .1 807 .3
2003          
     1st Quarter   291 .9 202 .1
     2nd Quarter   304 .2 167 .5
     3rd Quarter   308 .3 161 .9
     4th Quarter   316 .6 196 .7
           
     Year   $   1,221 .0 $      728 .2

 

 

Note: There is no change to previously reported amounts for the Business-to-Business segment or other income (expense), net.

 

4


 

 

KIMBERLY-CLARK CORPORATION


 

DEPRECIATION EXPENSE, ASSETS AND CAPITAL SPENDING

BY BUSINESS SEGMENT (as reclassified)

 
($ millions)
Personal
Care
Consumer
Tissue
                
Depreciation               
2002   $   258 .2 $   271 .6
2003      262 .9    297 .5
                
Assets               
2002      4,381 .8    4,965 .4
2003      4,781 .9    5,796 .5
                
Capital Spending               
2002      323 .2    306 .9
2003      344 .4    366 .6

 

 

Note: There is no change to previously reported amounts for the Business-to-Business segment or items not allocated to the business segments.

 

 

5